Riskpilot← Back to searchSign inGet full accessLØKENSKOGEN UTVIKLING AS
ASActiveOrg 914900646Operagata 16, 0194 OsloDevelopment of building projects · NACE 6812Est. 20150 employees
Revenue 2025
NOK 0
EBITDA margin
—
+70% vs 2024
Equity ratio
19.7%
Financial strength
Net profit 2025
NOK -14K
+74% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -17K | +70% |
| Net profit | NOK -14K | +74% |
| Total assets | NOK 1,3M | -54% |
| Equity | NOK 259K | -5% |
| Employees | 0 | — |
Legal name
LØKENSKOGEN UTVIKLING AS
Org number
914900646
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
2. februar 2015
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å eie fast eiendom, drive eiendomsutvikling og drift av fast eiendom samt all annen virksomhet som står i forbindelse med dette, herunder også investering i aksjer og andre eierandeler i andre selskaper og foretak med virksomhet innen fast eiendom.
Address
Operagata 16, 0194 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 15 766 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 7 506 | −20 | −29 | −55 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 7 506 | −20 | −29 | −55 | −17 |
| Net financials | −43 | 2 | 2 | 3 | 3 |
| Profit before tax | 7 463 | −17 | −26 | −52 | −14 |
| Tax | 1 642 | −0 | −0 | −0 | −0 |
| Net profit | 5 821 | −17 | −26 | −52 | −14 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 439 | 3 211 | 3 047 | 2 852 | 1 317 |
| Equity | 1 869 | 1 851 | 1 825 | 273 | 259 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 917 | 837 | 831 | 2 318 | 927 |
| Total debt | 1 570 | 1 360 | 1 222 | 2 579 | 1 058 |
EBITDA margin
-1658500.0%
This company
15.8%
Market median
-10496935% vs market
20212025
Equity ratio
19.7%
This company
38.2%
Market median
-48% vs market
20212025
Return on equity
-5.3%
This company
18.4%
Market median
-129% vs market
20212025
Net profit margin
-1366100.0%
This company
8.1%
Market median
-16865532% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
4.08×
This company
0.62×
Market median
-558% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KW Chief Executive Officer | Chief Executive Officer | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Chairman | 2017 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tertit Invest As
LØKENSKOGEN UTVIKLING AS Board members of LØKENSKOGEN UTVIKLING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristin Woje Ellingsen | Chief Executive Officer | 0 companies |
| Richard Urbanski | Board of Directors | 0 companies |
| Vidar Sandermoen | Chairman | 0 companies |
| Werner Isaksen | Board of Directors | 0 companies |
| Roar Flaathen | Chairman | 0 companies |